CDTX logo

Cidara Therapeutics (CDTX)

Profile

Full Name

Cidara Therapeutics, Inc.

Ticker Symbol

CDTX

Exchange

NASDAQ

Country

United States

IPO

April 15, 2015

Indexes

Not included

Employees

38

Key Details

Price

$20.00(+6.72%)

Market cap

$219.07M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.27M(-94.52% YoY)

Annual EPS

-$26.75(-409.52% YoY)

PE ratio

-

Next earnings date

Apr 22, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Buy
Mar 12, 25 Citizens Capital Markets
Market Outperform
Mar 10, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Needham
Buy
Dec 13, 24 RBC Capital
Outperform
Dec 5, 24 WBB Securities
Strong Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Guggenheim
Buy
Aug 14, 24 Needham
Buy
Aug 14, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Cidara Therapeutics?
  • Does Cidara Therapeutics pay dividends?
  • What sector is Cidara Therapeutics in?
  • What industry is Cidara Therapeutics in?
  • What country is Cidara Therapeutics based in?
  • When did Cidara Therapeutics go public?
  • Is Cidara Therapeutics in the S&P 500?
  • Is Cidara Therapeutics in the NASDAQ 100?
  • Is Cidara Therapeutics in the Dow Jones?
  • When was Cidara Therapeutics's last earnings report?
  • When does Cidara Therapeutics report earnings?
  • Should I buy Cidara Therapeutics stock now?

What is the ticker symbol for Cidara Therapeutics?

The ticker symbol for Cidara Therapeutics is NASDAQ:CDTX

Does Cidara Therapeutics pay dividends?

No, Cidara Therapeutics does not pay dividends

What sector is Cidara Therapeutics in?

Cidara Therapeutics is in the Healthcare sector

What industry is Cidara Therapeutics in?

Cidara Therapeutics is in the Biotechnology industry

What country is Cidara Therapeutics based in?

Cidara Therapeutics is headquartered in United States

When did Cidara Therapeutics go public?

Cidara Therapeutics's initial public offering (IPO) was on April 15, 2015

Is Cidara Therapeutics in the S&P 500?

No, Cidara Therapeutics is not included in the S&P 500 index

Is Cidara Therapeutics in the NASDAQ 100?

No, Cidara Therapeutics is not included in the NASDAQ 100 index

Is Cidara Therapeutics in the Dow Jones?

No, Cidara Therapeutics is not included in the Dow Jones index

When was Cidara Therapeutics's last earnings report?

Cidara Therapeutics's most recent earnings report was on Nov 7, 2024

When does Cidara Therapeutics report earnings?

The next expected earnings date for Cidara Therapeutics is Apr 22, 2025

Should I buy Cidara Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page